Answer
Lenvatinib selectively inhibits the kinase activities of VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4).
Sources for this answer
- Lenvatinib Eisai 4mg hard capsulesEisai Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 32Document updated
Sources checked